| |
Vitamin D Range |
| Variables |
< 20 ng/ml |
20 to 32 ng/ml |
> 32 ng/ml |
| n (%) |
n (%) |
n (%) |
| Sex |
|
|
|
| Boys |
3 (9.7) |
13 (41.9) |
15 (48.4) |
| Girls |
6 (20.0) |
9 (30.0) |
15 (50.0) |
| Age (years) |
|
|
|
| 0–3 years |
5 (21.7) |
5 (21.7) |
13 (56.5) |
| 4–10 years |
2 (9.5) |
7 (33.3) |
12 (57.1) |
| > 11 years |
2 (11.8) |
10 (58.8) |
5 (29.4) |
| Race |
|
|
|
| Caucasian |
5 (10.4) |
17(35.4) |
26 (54.2) |
| Asian |
1 (100) |
0 (0) |
0 (0) |
| Black |
2 (50) |
0 (0) |
2 (50) |
| Other |
1 (12.5) |
5 (62.5) |
2 (25.0) |
| Sillence type |
|
|
|
| Type I |
4 (12.9) |
8 (25.8) |
19 (61.3) |
| Type III |
2 (14.2) |
6 (42.9) |
6 (42.9) |
| Type IV |
3 (18.8) |
8 (50.0) |
5 (31.2) |
| BMI |
|
|
|
| Low (< 5%) |
2 (28.6) |
3 (42.9) |
2 (28.6) |
| Normal (5%–95%) |
2 (7.4) |
9 (33.3) |
16 (59.3) |
| High (> 95%) |
1 (14.3) |
4 (57.1) |
2 (28.6) |
| Fracture count |
|
|
|
| < 10 |
4 (13.8) |
8 (27.6) |
17 (58.6) |
| > 10 |
5 (15.6) |
14 (43.8) |
13 (40.6) |
| Pamidronate treatment |
|
|
|
| Without treatment |
4 (17.4) |
5 (21.7) |
14 (60.9) |
| With treatment |
5 (13.2) |
17 (44.7) |
16 (42.1) |
| Season |
|
|
|
| Winter |
3 (15.8) |
6 (31.6) |
10 (52.6) |
| Spring |
2 (20.0) |
4 (40.0) |
4 (40.0) |
| Summer |
4 (20.0) |
7 (35.0) |
9 (45.0) |
| Autumn |
0 (0) |
5 (41.7) |
7 (58.3) |
Abbreviations and notes:
Descriptive statistics of vitamin D categories and its distribution among study
variables.
BMI, body mass index |